81
Views
11
CrossRef citations to date
0
Altmetric
Drug Profile

Selective and specific If inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease

&
Pages 959-973 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Talla A. Rousan, Sunil T. Mathew & Udho Thadani. (2016) The risk of cardiovascular side effects with anti-anginal drugs. Expert Opinion on Drug Safety 15:12, pages 1609-1623.
Read now

Articles from other publishers (9)

Teresa Pasqua, Teresa Tropea, Maria Concetta Granieri, Anna De Bartolo, Angela Spena, Francesco Moccia, Carmine Rocca & Tommaso Angelone. (2022) Novel molecular insights and potential approaches for targeting hypertrophic cardiomyopathy: Focus on coronary modulators. Vascular Pharmacology 145, pages 107003.
Crossref
Talla A Rousan & Udho Thadani. (2019) Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence. European Cardiology Review 14:1, pages 18-22.
Crossref
Talla A. Rousan, Sunil T. Mathew & Udho Thadani. (2017) Drug Therapy for Stable Angina Pectoris. Drugs 77:3, pages 265-284.
Crossref
Alberto Dominguez-Rodriguez. 2015. Pharmacological Treatment of Chronic Stable Angina Pectoris. Pharmacological Treatment of Chronic Stable Angina Pectoris 135 152 .
Susanne Scheruebel, Chintan N. Koyani, Seth Hallström, Petra Lang, Dieter Platzer, Heinrich Mächler, Karl Lohner, Ernst Malle, Klaus Zorn-Pauly & Brigitte Pelzmann. (2014) If blocking potency of ivabradine is preserved under elevated endotoxin levels in human atrial myocytes. Journal of Molecular and Cellular Cardiology 72, pages 64-73.
Crossref
Brian A. HoustonGerin R. Stevens. (2015) Hypertrophic Cardiomyopathy: A Review. Clinical Medicine Insights: Cardiology 8s1, pages CMC.S15717.
Crossref
Buntaro Fujita, Marcus Franz, Bjoern Goebel, Michael Fritzenwanger, Hans R. Figulla, Friedhelm Kuethe, Markus Ferrari & Christian Jung. (2012) Prognostic relevance of heart rate at rest for survival and the quality of life in patients with dilated cardiomyopathy. Clinical Research in Cardiology 101:9, pages 701-707.
Crossref
Roberto Spoladore, Martin S. Maron, Rossella D'Amato, Paolo G. Camici & Iacopo Olivotto. (2012) Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence. European Heart Journal 33:14, pages 1724-1733.
Crossref
Lorenza Speranza, Sara Franceschelli & Graziano Riccioni. (2012) The Biological Effects of Ivabradine in Cardiovascular Disease. Molecules 17:5, pages 4924-4935.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.